Welcome to the American Family Physician podcast for the June 15th, 2017 issue.

I'm Steve.

I'm Kalina.

I'm Evan.

I'm Brett. We are residents and faculty,

mostly residents from the University of Arizona College of Medicine Phoenix, family medicine

residency. This time on the podcast, we're going to discuss Alzheimer disease, non-alcoholic

fatty liver disease, bariatric surgery, slipped capital femoral epiphasis, I dare you

sisomab, and an update from the American Academy of Pediatrics on Sudden Infant Death Syndrome.

The opinions expressed in the podcast are our own and do not represent the opinions of the

American Academy of Family Physicians, the editor of American Family Physician, or Banner Health.

Do not use this podcast for medical advice.

Instead, see your own family doctor for medical care.

First, we're going to talk about Alzheimer's disease, pharmacologic, and non-pharmacologic therapies for cognitive and functional symptoms from doctors Eperley, Dune, and Boise, out of Boise, Idaho.

Okay, so your first task is to assess your patient for Alzheimer's disease and dementia.

We talked about how to do this in episode 24. Make sure you're using a diagnostic tool to evaluate cognitive function and assessing IADLs and ADLs. Once you diagnose the disease, you may consider

starting pharmacologic therapy. Our first category of medications are

cholinesterase inhibitors. The three most commonly prescribed in this category are dinepazil,

galantamine, and rivistigmin. So what does the evidence show about these medications? There's

evidence of minor benefit of cognitive and functional status improvements, but the benefit

effects haven't been

translated into consistent patient-oriented outcomes, such as things like quality of life or

...